THE EFFECT OF POLY I: C AND IUDR ON THE INHIBITION OF HSV IN RABBIT EYESSMETANA O; EYLAN E; KARIV N et al.1982; MED. MICROBIOL. IMMUNOL.; ISSN 0300-8584; DEU; DA. 1982; VOL. 171; NO 2; PP. 99-112; BIBL. 39 REF.Article

2.119.012 (B) (7146146). - 22DECEMBRE 1971. PREPARATION DE LA 5-IODO-DESOXY-URIDINEsdPatent

TERATOGENIC EFFECTS OF THE PYRIMIDINE ANALOGUES 5-IODODEOXY-URIDINE AND CYTOSINE ARABINOSIDE IN LATE FETAL MICE AND RATS = EFFETS TERATOGENES DES IODO-5 DESOXYURIDINE ET CYTOSINE ARABINOSIDE, ANALOGUES DE LA PYRIMIDINE, CHEZ LES FOETUS AGES DE SOURIS ET DE RATPERCY DH.1975; TERATOLOGY; U.S.A.; DA. 1975; VOL. 11; NO 1; PP. 103-117; BIBL. 1 P.Article

IDOXURIDINE AND IODIZATION IN THE TREATMENT OF SIMPLE DENDRITIC ULCERATIONAUSTIN DJ; WALKER WM.1974; TRANS. OPHTHALMOL. SOC. U.K.; G.B.; DA. 1974; VOL. 94; NO 2; PP. 553-562; BIBL. 11REF.Serial Issue

PROPERTIES OF ADENOVIRUS SUBSTITUTED WITH IODODEOXYURIDINE. BRIEF REPORTWIGAND R; KLEIN W.1974; ARCH. GES. VIRUSFORSCH.; OESTERR.; DA. 1974; VOL. 45; NO 3; PP. 298-300; BIBL. 8REF.Article

STIMULATION OF HEMOLYSIN PLAQUE-FORMING CELLS BY IDOXURIDINEGRISWOLD DE; HEPPNER GH; CALABRESI P et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 1; PP. 88-92; BIBL. 20REF.Article

HAEMATOLOGICAL COMPLICATIONS OF THERAPY WITH PYRIMIDINE ANALOGUESGEARY CG.1973; POSTGRAD. MED. J.; G.B.; DA. 1973; VOL. 49; NO 572; PP. 413-439 (6P.); BIBL. 14REF.; (ACUTE NECROTIZING ENCEPHALITIS AND OTHER HERPES SIMPLEX VIRUS INFECT. SYMP.; MANCHESTER; 1972)Conference Paper

IDOXURIDINE IN HERPES SIMPLEX VIRUS (TYPE 1) ENCEPHALITIS. EXPERIENCE WITH 29 CASES IN MICHIGAN, 1966 TO 1971 = IDOXURIDINE DANS L'ENCEPHALITE HERPETIQUE A VIRUS SIMPLEX (TYPE 1). EXPERIMENTATION A PROPOS DE 29CAS DANS LE MICHIGAN DE 1966 A 1971NOLAN DC; LAUTER CB; LERNER AM et al.1973; ANN. INTERN. MED.; U.S.A.; DA. 1973; VOL. 78; NO 2; PP. 243-246; BIBL. 11REF.Serial Issue

OCULAR DEFECTS IN NEWBORN RATS TREATED WITH 5-IODODEOXYURIDINE = ANOMALIES OCULAIRES CHEZ LES RATS NOUVEAU-NES TRAITES PAR L'IODO-5 DESOXYURIDINEPERCY DH; ALBERT DM; AMEMIYA T et al.1973; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1973; VOL. 142; NO 4; PP. 1272-1276; BIBL. 19REF.Serial Issue

ANTIVIRAL DRUGS IN JAKOB-CREUTZFELDT DISEASE = MEDICAMENTS ANTIVIRAUX DANS LA MALADIE DE CREUTZFELDT-JACOBHERISHANU Y.1973; J. AMER. GERIATR. SOC.; U.S.A.; DA. 1973; VOL. 21; NO 5; PP. 229-231; BIBL. 9REF.Serial Issue

MEASUREMENTS OF IN VIVO EFFECTS OF AN ELECTRON-AFFINIC RADIOSENSITIZER USING A DOUBLE TRACER TECHNIQUEGEWEHR K; PORSCHEN W; MUEHLENSIEPEN H et al.1980; STRAHLENTHERAPIE; ISSN 0039-2073; DEU; DA. 1980; VOL. 156; NO 8; PP. 554-560; ABS. GER/FRE; BIBL. 53 REF.Article

PROGRAMMING OF EVENTS IN EPSTEIN-BARR VIRUS- ACTIVATED CELLS INDUCED BY 5-IODODEOXYURIDINE = PROGRAMMATION DES EVENEMENTS INDUITS PAR LA 5-IODODEOXYURIDINE DANS LES CELLULES ACTIVEES PAR LE VIRUS D'E.B.HAMPAR B; DERGE JG; NONOYAMA M et al.1974; VIROLOGY; U.S.A.; DA. 1974; VOL. 62; NO 1; PP. 71-89; BIBL. 1P.Article

FIXATIONS COMPAREES DE L'IODO-5 DEOXY 2URIDINE ET DE THYMIDINE DANS LES NOYAUX DE CELLULES HELA INFECTEES PAR LE VIRUS HERPETIQUEMATSUMURA K; GO T.1972; ACTA SOC. OPHTHALMOL. JAP.; JAP.; DA. 1972; VOL. 76; NO 8; PP. 642-645; ABS. ANGL.; BIBL. 15REF.Serial Issue

ENHANCEMENT OF ADENOVIRUS INFECTION IN WI-38 AND AGMK CELLS BY PRETREATMENT OF CELLS WITH 5-IODODEOXYURIDINESTAAL SP; ROWE WP.1975; VIROLOGY; U.S.A.; DA. 1975; VOL. 64; NO 2; PP. 513-519; BIBL. 19REF.Article

TERATOGENICITIES OF OPHTHALMIC DRUGS. I. ANTIVIRAL OPHTHALMIC DRUGS. = TERATOGENICITE DES MEDICAMENTS OPHTALMIQUES. I. MEDICAMENTS ANTIVIRAUXITOI M; GEFTER JW; KANEKO N et al.1975; ARCH. OPHTHALMOL.; U.S.A.; DA. 1975; VOL. 93; NO 1; PP. 46-51; BIBL. 13 REF.Article

IODODEOXYURIDINE AND HERPESVIRAL ENCEPHALITIS: LACK OF INHIBITORY ACTION AGAINST LOW-GRADE VIRAL REPLICATIONPLUMMER G; INGERSON AP.1974; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1974; VOL. 5; NO 6; PP. 672-673; BIBL. 5REF.Article

POTENTATION BY FLUORODEOXYURIDINE OF ¹²⁵I-DEOXYURIDINE UPTAKE BY HUMAN AND CHICKEN LYMPHOCYTES IN THE QUANTITATION OF MITOGENIC RESPONSEASANTILA T; TOIVANEN P.1974; J. IMMUNOL. METHODS; NETHERL.; DA. 1974; VOL. 6; NO 1-2; PP. 73-82; BIBL. 17REF.Article

ANTIVIRAL CHEMOTHERAPY = CHIMIOTHERAPIE ANTIVIRALELUBY JP; JOHNSON MT; JONES SR et al.1974; ANNU. REV. MED.; U.S.A.; DA. 1974; VOL. 25; PP. 251-267; BIBL. 2P.Article

Predisposition of [¹²⁵I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages = Prédisposition des fibroblastes de souris normaux et cancéreux marqués à la 5-iodo-2' désoxyuridine (I125) à la lyse par les macrophages normauxEVANS, R; EIDLEN, D. M.Journal of the National Cancer Institute. 1983, Vol 71, Num 5, pp 983-989, issn 0027-8874Article

CHIMIOTHERAPIE ANTIVIRALEVILDE JL; BRICAIRE F; BASTIN R et al.1979; REV. PRATICIEN; FRA; DA. 1979; VOL. 29; NO 37; PP. 2925-2928; ABS. ENG; BIBL. 3 REF.Article

PROFLAVINE PHOTODYNAMIC VIRAL INACTIVATION IN HERPES SIMPLEX KERATITIS = INACTIVATION VIRALE PAR PHOTODYNAMIQUE AVEC PROFLAVINE DANS LA KERATITE HERPETIQUEO'DAY DM; JONES BR; POIRIER R et al.1975; AMER. J. OPHTHALMOL.; U.S.A.; DA. 1975; VOL. 79; NO 6; PP. 941-948; BIBL. 12 REF.Article

ANTI-VIRAL TREATMENT OF WARTS = TRAITEMENT ANTI-VIRAL DES VERRUESMORISON WL.1975; BRIT. J. DERMATOL.; G.B.; DA. 1975; VOL. 92; NO 1; PP. 97-99; BIBL. 3 REF.Article

PROFLAVINE AND LIGHT IN THE TREATMENT OF EXPERIMENTAL HERPETIC OCULAR INFECTIONSLANIER JD; WHITCHER JP; DAWSON CR et al.1974; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1974; VOL. 6; NO 5; PP. 613-619; BIBL. 13 REF.Article

5-IODO-2-DEOXYURIDINE (IUDR; NSC-39661) GIVEN INTRAVENTRICULARLY IN THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHYTARSY D; HOLDEN EM; SEGARRA JM et al.1973; CANCER CHEMOTHERAPY REP., I; U.S.A.; DA. 1973; VOL. 57; NO 1; PP. 73-78; BIBL. 29REF.Serial Issue

Topical liposomal gel of idoxuridine for the treatment of herpes simplex: Pharmaceutical and clinical implicationsAVINASH KUMAR SETH; MISRA, Ambikanandan; UMRIGAR, Dipak et al.Pharmaceutical development and technology. 2004, Vol 9, Num 3, pp 277-289, issn 1083-7450, 13 p.Article